147 related articles for article (PubMed ID: 38113033)
1. Therapeutic Hope on the Surface of Ewing Sarcoma.
Bailey KM
Clin Cancer Res; 2024 Mar; 30(5):934-936. PubMed ID: 38113033
[TBL] [Abstract][Full Text] [Related]
2. Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.
Mooney B; Negri GL; Shyp T; Delaidelli A; Zhang HF; Spencer Miko SE; Weiner AK; Radaoui AB; Shraim R; Lizardo MM; Hughes CS; Li A; El-Naggar AM; Rouleau M; Li W; Dimitrov DS; Kurmasheva RT; Houghton PJ; Diskin SJ; Maris JM; Morin GB; Sorensen PH
Clin Cancer Res; 2024 Mar; 30(5):1022-1037. PubMed ID: 37812652
[TBL] [Abstract][Full Text] [Related]
3. Targeting the tumor microenvironment of Ewing sarcoma.
Morales E; Olson M; Iglesias F; Luetkens T; Atanackovic D
Immunotherapy; 2021 Dec; 13(17):1439-1451. PubMed ID: 34670399
[TBL] [Abstract][Full Text] [Related]
4. Next steps in preventing Ewing sarcoma progression.
Knott MM; Dallmayer M; Grünewald TG
Future Oncol; 2016 Jan; 12(1):1-4. PubMed ID: 26615856
[No Abstract] [Full Text] [Related]
5. Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes.
Sand LG; Szuhai K; Hogendoorn PC
Int J Mol Sci; 2015 Jul; 16(7):16176-215. PubMed ID: 26193259
[TBL] [Abstract][Full Text] [Related]
6. Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy.
Sand LG; Berghuis D; Szuhai K; Hogendoorn PC
Cancer Immunol Immunother; 2016 Aug; 65(8):995-1002. PubMed ID: 27369431
[TBL] [Abstract][Full Text] [Related]
7. [Functional genomics of Ewing sarcoma].
Grünewald TGP
Pathologe; 2017 Nov; 38(Suppl 2):198-201. PubMed ID: 28849372
[TBL] [Abstract][Full Text] [Related]
8. Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target.
Town J; Pais H; Harrison S; Stead LF; Bataille C; Bunjobpol W; Zhang J; Rabbitts TH
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3603-8. PubMed ID: 26979953
[TBL] [Abstract][Full Text] [Related]
9. Ewing Sarcoma, an Update on Molecular Pathology with Therapeutic Implications.
de Alava E
Surg Pathol Clin; 2017 Sep; 10(3):575-585. PubMed ID: 28797503
[TBL] [Abstract][Full Text] [Related]
10. Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.
Potratz J; Tillmanns A; Berning P; Korsching E; Schaefer C; Lechtape B; Schleithoff C; Unland R; Schäfer KL; Müller-Tidow C; Jürgens H; Dirksen U
Mol Oncol; 2016 May; 10(5):677-92. PubMed ID: 26739507
[TBL] [Abstract][Full Text] [Related]
11. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
[TBL] [Abstract][Full Text] [Related]
12. Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma.
Zhang HF; Hughes CS; Li W; He JZ; Surdez D; El-Naggar AM; Cheng H; Prudova A; Delaidelli A; Negri GL; Li X; Ørum-Madsen MS; Lizardo MM; Oo HZ; Colborne S; Shyp T; Scopim-Ribeiro R; Hammond CA; Dhez AC; Langman S; Lim JKM; Kung SHY; Li A; Steino A; Daugaard M; Parker SJ; Geltink RIK; Orentas RJ; Xu LY; Morin GB; Delattre O; Dimitrov DS; Sorensen PH
Cancer Discov; 2021 Nov; 11(11):2884-2903. PubMed ID: 34021002
[TBL] [Abstract][Full Text] [Related]
13. New strategies in ewing sarcoma: lost in translation?
Arnaldez FI; Helman LJ
Clin Cancer Res; 2014 Jun; 20(12):3050-6. PubMed ID: 24756371
[TBL] [Abstract][Full Text] [Related]
14. Ewing sarcoma: biology-based therapeutic perspectives.
Potratz J; Jürgens H; Craft A; Dirksen U
Pediatr Hematol Oncol; 2012 Feb; 29(1):12-27. PubMed ID: 22304007
[TBL] [Abstract][Full Text] [Related]
15. Exploiting Replication Stress as a Novel Therapeutic Intervention.
Martin JC; Hoegel TJ; Lynch ML; Woloszynska A; Melendy T; Ohm JE
Mol Cancer Res; 2021 Feb; 19(2):192-206. PubMed ID: 33020173
[TBL] [Abstract][Full Text] [Related]
16. Cellular immunotherapy strategies for Ewing sarcoma.
Rossig C
Immunotherapy; 2014; 6(5):611-21. PubMed ID: 24896629
[TBL] [Abstract][Full Text] [Related]
17. EZH2 Inhibition in Ewing Sarcoma Upregulates G
Kailayangiri S; Altvater B; Lesch S; Balbach S; Göttlich C; Kühnemundt J; Mikesch JH; Schelhaas S; Jamitzky S; Meltzer J; Farwick N; Greune L; Fluegge M; Kerl K; Lode HN; Siebert N; Müller I; Walles H; Hartmann W; Rossig C
Mol Ther; 2019 May; 27(5):933-946. PubMed ID: 30879952
[TBL] [Abstract][Full Text] [Related]
18. The potential of KDM3A as a therapeutic target in Ewing Sarcoma and other cancers.
Jedlicka P
Expert Opin Ther Targets; 2017 Nov; 21(11):997-999. PubMed ID: 29022407
[No Abstract] [Full Text] [Related]
19. Ewing sarcoma treatment: a gene therapy approach.
Tsibulnikov S; Fayzullina D; Karlina I; Schroeder BA; Karpova O; Timashev P; Ulasov I
Cancer Gene Ther; 2023 Aug; 30(8):1066-1071. PubMed ID: 37037906
[TBL] [Abstract][Full Text] [Related]
20. Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells.
Visser LL; Bleijs M; Margaritis T; van de Wetering M; Holstege FCP; Clevers H
Cancer Res Commun; 2023 Oct; 3(10):2158-2169. PubMed ID: 37823774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
